SUBMOX 500 mg Capsules
(Amoxicillin 500 mg)
Generic Name:
Amoxicillin
Therapeutic Group:
Antibacterial
Drug Category:
Aminopenicillin (Beta-Lactam Antibiotic)
Content / Composition:
Each capsule contains:
Amoxicillin (as Amoxicillin Trihydrate) ……… 500 mg
Excipients ………………………………………… q.s.
Indications:
SUBMOX 500 mg is indicated for the treatment of:
Upper respiratory tract infections (pharyngitis, tonsillitis, sinusitis)
Lower respiratory infections (bronchitis, pneumonia)
Urinary tract infections (UTIs)
Skin and soft tissue infections
Ear infections (otitis media)
Dental infections
Gastrointestinal infections (including H. pylori in combination therapy)
Dosage:
Adults & Adolescents:
500 mg every 8 hours
یا
500–1000 mg every 12 hours
Severe infections:
Dose may be increased under physician supervision
Duration:
Usually 5–10 days
Contraindications:
Hypersensitivity to penicillins or beta-lactam antibiotics
History of anaphylaxis to antibiotics
Infectious mononucleosis (risk of rash)
Administration:
Oral use
Can be taken with or without food
Swallow capsule with water
Complete full treatment course
Drug Interactions:
Probenecid → increases plasma levels
Allopurinol → increased risk of rash
Oral contraceptives → reduced effectiveness
Anticoagulants → monitor INR
Compatibility / Clinical Benefits:
Broad-spectrum antibacterial activity
Effective against Gram-positive and some Gram-negative bacteria
First-line therapy for many common infections
Good safety profile
Flexible dosing regimen
Stability / Storage:
Store below 25°C
Protect from moisture
Keep in original packaging
Precautions:
Use cautiously in renal impairment
Monitor for hypersensitivity reactions
Long-term use may cause superinfection
Avoid misuse to prevent resistance
Side Effects:
Common:
Nausea
Diarrhea
Mild rash
Uncommon:
Vomiting
Abdominal pain
Serious (Rare):
Anaphylaxis
Stevens-Johnson Syndrome
Antibiotic-associated colitis
Clinical Advantages:
SUBMOX 500 mg provides:
Reliable first-line antibiotic therapy
Effective in community infections
Fast symptom relief
Widely trusted safety profile
Packaging:
10 × 2 Capsules (Blister Pack)

CEFNUS 200 mg Capsules
(Cefixime 200 mg)
Generic Name:
Cefixime
Therapeutic Group:
Antibacterial
Drug Category:
Third-Generation Cephalosporin Antibiotic
Content / Composition:
Each capsule contains:
Cefixime ………………………………… 200 mg
Excipients ……………………………… q.s.
Indications:
CEFNUS is indicated for the treatment of susceptible bacterial infections including:
Upper respiratory tract infections (pharyngitis, tonsillitis, sinusitis)
Lower respiratory tract infections (bronchitis)
Urinary tract infections (UTIs)
Ear infections (otitis media)
Typhoid fever
Uncomplicated gonorrhea
Gastrointestinal infections
Dosage:
Adults & Adolescents:
200 mg twice daily
یا
400 mg once daily
Duration:
Usually 5–10 days depending on infection
Contraindications:
Hypersensitivity to cephalosporins or beta-lactam antibiotics
History of severe allergic reactions to penicillins
Administration:
Oral use
Can be taken with or without food
Swallow capsule with water
Complete full prescribed course
Drug Interactions:
Anticoagulants → increased bleeding risk
Carbamazepine → increased levels
Probenecid → may increase cefixime levels
Compatibility / Clinical Benefits:
Broad-spectrum antibacterial activity
Effective against Gram-positive and Gram-negative bacteria
High stability against beta-lactamase enzymes
Convenient once-daily dosing option
Ideal for outpatient therapy
Stability / Storage:
Store below 25°C
Protect from moisture and light
Keep in original packaging
Precautions:
Use with caution in renal impairment
Monitor for allergic reactions
Risk of antibiotic-associated colitis
Avoid unnecessary prolonged use
Side Effects:
Common:
Diarrhea
Nausea
Abdominal pain
Uncommon:
Headache
Dizziness
Skin rash
Serious (Rare):
Hypersensitivity reactions
Stevens-Johnson Syndrome
Severe diarrhea (C. difficile-associated)
Clinical Advantages:
CEFNUS 200 mg provides:
Advanced third-generation antibiotic coverage
Effective against resistant organisms
Convenient dosing (once daily option)
Strong choice for respiratory & systemic infections
Packaging:
10 × 1 Capsules (Blister Pack)

CEFNUS 400 mg Capsules
(Cefixime 400 mg)
Generic Name:
Cefixime
Therapeutic Group:
Antibacterial
Drug Category:
Third-Generation Cephalosporin Antibiotic
Content / Composition:
Each capsule contains:
Cefixime ………………………………… 400 mg
Excipients ……………………………… q.s.
Indications:
CEFNUS 400 mg is indicated for the treatment of moderate to severe bacterial infections including:
Upper respiratory tract infections (pharyngitis, tonsillitis, sinusitis)
Lower respiratory infections (acute & chronic bronchitis)
Urinary tract infections (UTIs)
Ear infections (otitis media)
Typhoid fever
Uncomplicated gonorrhea
Gastrointestinal infections
Dosage:
Adults & Adolescents:
400 mg once daily
یا
200 mg twice daily
Duration:
Typically 5–10 days
Typhoid fever: 7–14 days (as per physician)
Contraindications:
Hypersensitivity to cephalosporins or beta-lactam antibiotics
History of severe allergic reactions
Administration:
Oral use
Can be taken with or without food
Swallow capsule with water
Complete full prescribed course
Drug Interactions:
Anticoagulants → increased bleeding risk
Carbamazepine → increased plasma levels
Probenecid → may increase cefixime concentration
Compatibility / Clinical Benefits:
Broad-spectrum antibacterial activity
Strong efficacy against Gram-negative pathogens
High resistance to beta-lactamase enzymes
Convenient once-daily dosing
Ideal for outpatient and step-down therapy
Stability / Storage:
Store below 25°C
Protect from moisture and light
Keep in original packaging
Precautions:
Use with caution in renal impairment
Monitor for allergic reactions
Risk of antibiotic-associated diarrhea/colitis
Avoid prolonged or unnecessary use
Side Effects:
Common:
Diarrhea
Nausea
Abdominal pain
Uncommon:
Headache
Dizziness
Skin rash
Serious (Rare):
Hypersensitivity reactions
Stevens-Johnson Syndrome
Severe colitis (C. difficile)
Clinical Advantages:
CEFNUS 400 mg provides:
High-strength third-generation antibiotic therapy
Convenient once-daily dosing improves compliance
Effective against resistant and complicated infections
Strong choice for respiratory & systemic infections
Packaging:
1 × 5 Capsules (Blister Pack)

CEFNUS Pediatric Suspension
(Cefixime 200 mg/5 mL)
Generic Name:
Cefixime
Therapeutic Group:
Antibacterial
Drug Category:
Third-Generation Cephalosporin Antibiotic
Content / Composition:
After reconstitution, each 5 mL contains:
Cefixime ………………………………… 200 mg
Excipients (including flavoring agents) … q.s.
Indications:
CEFNUS Suspension is indicated for the treatment of bacterial infections in children, including:
Upper respiratory tract infections (tonsillitis, pharyngitis, sinusitis)
Lower respiratory tract infections (bronchitis, pneumonia)
Otitis media (ear infection)
Urinary tract infections (UTIs)
Typhoid fever
Gastrointestinal infections
Dosage:
Children (6 months and above):
8 mg/kg/day as a single dose
یا
Divided into two doses (4 mg/kg every 12 hours)
Maximum Dose:
400 mg/day
Duration:
معمولاً 5–10 روز
Typhoid: 7–14 days (as prescribed)
Contraindications:
Hypersensitivity to cefixime or cephalosporins
Known allergy to beta-lactam antibiotics
Administration:
For oral use only
Shake well before use
Use measuring cup or syringe for accurate dosing
Can be given with or without food
Complete full course
Drug Interactions:
Anticoagulants → may increase bleeding risk
Carbamazepine → increased serum levels
Probenecid → increases cefixime concentration
Compatibility / Clinical Benefits:
Pediatric-friendly formulation
Pleasant flavored suspension improves compliance
Broad-spectrum activity against common pathogens
Once-daily dosing option
Effective in outpatient pediatric therapy
Stability / Storage:
Store dry powder below 25°C before reconstitution
After reconstitution:
Use within 7–14 days
Keep tightly closed
Do not freeze
Precautions:
Use with caution in renal impairment
Monitor for allergic reactions
Risk of antibiotic-associated diarrhea
Avoid unnecessary prolonged use
Side Effects:
Common:
Diarrhea
Nausea
Abdominal discomfort
Uncommon:
Rash
Headache
Serious (Rare):
Hypersensitivity reactions
Stevens-Johnson Syndrome
Severe colitis
Clinical Advantages:
CEFNUS Pediatric Suspension offers:
Safe and effective antibiotic for children
Accurate weight-based dosing
Improved taste → better compliance
Strong efficacy in respiratory & systemic infections
Packaging:
30 mL bottle (after reconstitution)
With measuring cup / oral syringe

CEFNUS Pediatric Suspension
(Cefixime 100 mg/5 mL)
Generic Name:
Cefixime
Therapeutic Group:
Antibacterial
Drug Category:
Third-Generation Cephalosporin Antibiotic
Content / Composition:
After reconstitution, each 5 mL contains:
Cefixime ………………………………… 100 mg
Excipients (including flavoring agents) … q.s.
Indications:
CEFNUS 100 mg/5 mL Suspension is indicated for pediatric use in:
Upper respiratory tract infections (pharyngitis, tonsillitis, sinusitis)
Lower respiratory infections (bronchitis, pneumonia)
Otitis media
Urinary tract infections (UTIs)
Typhoid fever
Gastrointestinal bacterial infections
Dosage:
Children (≥ 6 months):
8 mg/kg/day as a single daily dose
یا
4 mg/kg every 12 hours
Maximum Dose:
400 mg/day
Typical Duration:
5–10 days
Typhoid: 7–14 days (as directed by physician)
Contraindications:
Hypersensitivity to cefixime or cephalosporins
Severe allergy to penicillins (cross-reactivity risk)
Administration:
For oral use only
Reconstitute with clean water to marked level
Shake well before each use
Measure dose using syringe or cup
Can be taken with or without food
Drug Interactions:
Anticoagulants → increased bleeding risk
Carbamazepine → increased plasma levels
Probenecid → increases cefixime levels
Compatibility / Clinical Benefits:
مناسب برای کودکان (Pediatric-friendly)
Taste-enhanced formulation → better compliance
Once-daily dosing possible
Broad-spectrum antibacterial coverage
Effective in outpatient pediatric infections
Stability / Storage:
Store dry powder below 25°C
After reconstitution:
Use within 7–14 days
Keep tightly closed
Protect from light
Do not freeze
Precautions:
Use with caution in renal impairment
Monitor for hypersensitivity reactions
Risk of antibiotic-associated diarrhea
Avoid prolonged unnecessary use
Side Effects:
Common:
Diarrhea
Nausea
Abdominal pain
Uncommon:
Skin rash
Headache
Serious (Rare):
Anaphylaxis
Stevens-Johnson Syndrome
Clostridium difficile-associated diarrhea
Clinical Advantages:
CEFNUS 100 mg/5 mL offers:
Accurate pediatric dosing (low-strength flexibility)
High safety profile in children
Improved palatability → better adherence
Reliable efficacy against common infections
Packaging:
30 mL bottle (after reconstitution)
Measuring cup + oral syringe included

SBMOX Pediatric Suspension
(Amoxicillin 250 mg/5 mL)
Generic Name:
Amoxicillin
Therapeutic Group:
Antibacterial
Drug Category:
Aminopenicillin (Beta-lactam Antibiotic)
Content / Composition:
After reconstitution, each 5 mL contains:
Amoxicillin (as trihydrate) ………… 250 mg
Excipients (including flavoring agents) … q.s.
Indications:
SBMOX Suspension is indicated for the treatment of susceptible bacterial infections in children, including:
Upper respiratory tract infections (tonsillitis, pharyngitis, sinusitis)
Lower respiratory tract infections (bronchitis, pneumonia)
Otitis media
Urinary tract infections (UTIs)
Skin & soft tissue infections
Dental infections
Dosage:
Children:
20–40 mg/kg/day in divided doses (every 8 hours)

25–45 mg/kg/day in divided doses (every 12 hours)
Severe infections:
Up to 80–90 mg/kg/day (as prescribed)
Maximum Dose:
4 g/day
Duration:
5–10 days (depending on infection)
Contraindications:
Hypersensitivity to amoxicillin or penicillins
History of severe allergic reactions to beta-lactam antibiotics
Administration:
For oral use only
Reconstitute with clean water to marked level
Shake well before each use
Use measuring syringe or cup
May be taken with or without food
Drug Interactions:
Allopurinol → increased risk of rash
Oral anticoagulants → increased bleeding risk
Methotrexate → increased toxicity
Oral contraceptives → reduced efficacy (rare)
Compatibility / Clinical Benefits:
Pediatric-friendly formulation
Pleasant strawberry flavor improves compliance
Flexible dosing for mild to severe infections
Well-established safety profile
First-line antibiotic for many pediatric infections
Stability / Storage:
Store dry powder below 25°C
After reconstitution:
Use within 7–14 days
Keep tightly closed
Do not freeze
Protect from light
Precautions:
Use with caution in renal impairment
Monitor for hypersensitivity reactions
Prolonged use may lead to superinfection
Use carefully in patients with history of allergies
Side Effects:
Common:
Diarrhea
Nausea
Vomiting
Uncommon:
Skin rash
Urticaria
Serious (Rare):
Anaphylaxis
Stevens-Johnson Syndrome
Antibiotic-associated colitis
Clinical Advantages:
SBMOX Suspension offers:
Reliable first-line pediatric antibiotic
Flexible dosing for all severity levels
Excellent safety and tolerability
High compliance due to palatable taste
Packaging:
60 mL bottle (after reconstitution)
Measuring cup + oral syringe included

SBMOX Pediatric Suspension
(Amoxicillin 125 mg/5 mL)
Generic Name:
Amoxicillin
Therapeutic Group:
Antibacterial
Drug Category:
Aminopenicillin (Beta-lactam Antibiotic)
Content / Composition:
After reconstitution, each 5 mL contains:
Amoxicillin (as trihydrate) ………… 125 mg
Excipients (including flavoring agents) … q.s.
Indications:
SBMOX 125 mg/5 mL Suspension is indicated for pediatric use in:
Upper respiratory tract infections (pharyngitis, tonsillitis, sinusitis)
Lower respiratory tract infections (bronchitis, pneumonia)
Otitis media
Urinary tract infections (UTIs)
Skin & soft tissue infections
Dental infections
Dosage:
Children:
20–40 mg/kg/day in divided doses every 8 hours

25–45 mg/kg/day in divided doses every 12 hours
Severe infections:
Up to 80–90 mg/kg/day (as prescribed)
(125 mg/5 mL)
Contraindications:
Hypersensitivity to amoxicillin or penicillins
History of severe allergic reactions to beta-lactam antibiotics
Administration:
For oral use only
Reconstitute with clean water up to marked level
Shake well before each use
Use measuring syringe or cup
Can be taken with or without food
Drug Interactions:
Allopurinol → increased risk of rash
Anticoagulants → increased bleeding risk
Methotrexate → increased toxicity
Oral contraceptives (rare)
Compatibility / Clinical Benefits:
Easy dosing (low-strength flexibility)
Pleasant banana flavor improves compliance
Widely used first-line antibiotic
Safe and well tolerated
Stability / Storage:
Store dry powder below 25°C
After reconstitution:
Use within 7–14 days
Keep tightly closed
Do not freeze
Protect from light
Precautions:
Use with caution in renal impairment
Monitor for allergic reactions
Risk of superinfection with prolonged use
Use carefully in patients with history of asthma/allergy
Side Effects:
Common:
Diarrhea
Nausea
Vomiting
Uncommon:
Skin rash
Urticaria
Serious (Rare):
Anaphylaxis
Stevens-Johnson Syndrome
Antibiotic-associated colitis
Clinical Advantages:
SBMOX 125 mg/5 mL provides:
Precise dosing for infants & toddlers
High safety profile
Better compliance due to palatable taste
Effective treatment for common pediatric infections
Packaging:
60 mL bottle (after reconstitution)
Measuring cup + oral syringe included

SUBCLAV Pediatric Suspension
(Co-Amoxiclav 400 mg / 57 mg per 5 mL)
(Amoxicillin + Clavulanic Acid)
Generic Name:
Amoxicillin + Clavulanic Acid
Therapeutic Group:
Antibacterial
Drug Category:
Beta-lactam Antibiotic Combination (Aminopenicillin + Beta-lactamase Inhibitor)
Content / Composition:
After reconstitution, each 5 mL contains:
Amoxicillin (as trihydrate) ………… 400 mg
Clavulanic Acid (as potassium clavulanate) ………… 57 mg
Excipients ………………………………… q.s.
Indications:
SUBCLAV Suspension is indicated for pediatric treatment of infections caused by beta-lactamase producing organisms:
Upper respiratory tract infections (sinusitis, tonsillitis)
Lower respiratory tract infections (bronchitis, pneumonia)
Otitis media
Urinary tract infections (UTIs)
Skin & soft tissue infections
Dental infections
Dosage:
Children (≥ 3 months):
Based on amoxicillin component:
25–45 mg/kg/day divided every 12 hours
Severe infections:
Up to 45 mg/kg/day (in 2 divided doses)
Important:
Use dosing syringe for accuracy
Do not exceed recommended clavulanate exposure
Contraindications:
Hypersensitivity to penicillins or beta-lactam antibiotics
History of cholestatic jaundice or hepatic dysfunction associated with co-amoxiclav
Administration:
For oral use only
Reconstitute with clean water up to mark
Shake well before each use
Administer at the start of meals (improves tolerance)
Complete full course
Drug Interactions:
Allopurinol → increased risk of rash
Anticoagulants → prolonged bleeding time
Methotrexate → increased toxicity
Probenecid → increases amoxicillin levels
Compatibility / Clinical Benefits:
Broad-spectrum coverage including resistant bacteria
Effective against beta-lactamase producing organisms
Pediatric-friendly formulation
Improved clinical outcomes in resistant infections
Twice daily dosing improves compliance
Stability / Storage:
Store dry powder below 25°C
After reconstitution:
Refrigeration preferred (2–8°C)
Use within 7–10 days
Keep tightly closed
Do not freeze
Precautions:
Use with caution in hepatic impairment
Monitor liver function in prolonged use
Risk of antibiotic-associated diarrhea
Use cautiously in renal impairment
Avoid unnecessary prolonged therapy
Side Effects:
Common:
Diarrhea
Nausea
Vomiting
Uncommon:
Rash
Oral candidiasis
Serious (Rare):
Hepatic dysfunction
Anaphylaxis
Stevens-Johnson Syndrome
Pseudomembranous colitis
Clinical Advantages:
SUBCLAV provides:
Enhanced antibacterial spectrum
Effective against resistant infections
Combination therapy in single formulation
Improved pediatric compliance
Packaging:
60 mL bottle (after reconstitution)
Measuring cup + oral syringe included

SUBCLAV Pediatric Suspension
(Co-Amoxiclav 312.5 mg per 5 mL)
(Amoxicillin 250 mg + Clavulanic Acid 62.5 mg equivalent formulation)
Generic Name:
Amoxicillin + Clavulanic Acid
Therapeutic Group:
Antibacterial
Drug Category:
Beta-lactam Antibiotic Combination
(Aminopenicillin + Beta-lactamase Inhibitor)
Content / Composition:
After reconstitution, each 5 mL contains:
Amoxicillin (as trihydrate) ………… 250 mg
Clavulanic Acid (as potassium clavulanate) ………… 62.5 mg
Excipients ………………………………… q.s.
Indications:
SUBCLAV Suspension is indicated in pediatric patients for infections caused by beta-lactamase producing bacteria:
Upper respiratory tract infections (sinusitis, tonsillitis)
Lower respiratory tract infections (bronchitis, pneumonia)
Otitis media
Urinary tract infections (UTIs)
Skin & soft tissue infections
Dental infections
Dosage:
Children (≥ 3 months):
Based on amoxicillin component:
25–45 mg/kg/day divided every 12 hours
Severe infections:
Up to 45 mg/kg/day in 2 divided doses
Important Note:
Dose carefully to avoid excess clavulanate exposure
Always use calibrated measuring device
Contraindications:
Hypersensitivity to penicillins or beta-lactams
History of cholestatic jaundice or hepatic dysfunction due to co-amoxiclav
Administration:
For oral use only
Reconstitute with clean water up to indicated mark
Shake well before each use
Administer at the start of meals (reduces GI side effects)
Complete full course of therapy
Drug Interactions:
Allopurinol → increased risk of rash
Oral anticoagulants → prolonged bleeding
Methotrexate → increased toxicity
Probenecid → increases amoxicillin levels
Compatibility / Clinical Benefits:
Broad-spectrum antibacterial activity
Effective against resistant organisms
Optimized pediatric dosing strength
Better tolerability with food administration
Suitable for moderate to severe infections
Stability / Storage:
Store dry powder below 25°C
After reconstitution:
Preferably refrigerate (2–8°C)
Use within 7–10 days
Keep tightly closed
Do not freeze
Precautions:
Use with caution in hepatic impairment
Monitor liver function in prolonged therapy
Risk of antibiotic-associated diarrhea
Use carefully in renal impairment
Avoid unnecessary prolonged use
Side Effects:
Common:
Diarrhea
Nausea
Vomiting
Uncommon:
Skin rash
Oral candidiasis
Serious (Rare):
Hepatic dysfunction
Anaphylaxis
Stevens-Johnson Syndrome
Pseudomembranous colitis
Clinical Advantages:
SUBCLAV 312.5 mg/5 mL offers:
Balanced combination strength for pediatrics
Effective treatment of resistant infections
Improved dosing accuracy
High compliance due to palatable flavor
Packaging:
60 mL bottle (after reconstitution)
Measuring cup + oral syringe included

SUBCLAV Pediatric Suspension
(Co-Amoxiclav 156 mg / 25 mg per 5 mL)
(Amoxicillin + Clavulanic Acid)
Generic Name:
Amoxicillin + Clavulanic Acid
Therapeutic Group:
Antibacterial
Drug Category:
Beta-lactam Antibiotic Combination
(Aminopenicillin + Beta-lactamase Inhibitor)
Content / Composition:
After reconstitution, each 5 mL contains:
Amoxicillin (as trihydrate) ………… 156 mg
Clavulanic Acid (as potassium clavulanate) ………… 25 mg
Excipients ………………………………… q.s.
Indications:
Indicated in pediatric patients for treatment of infections caused by beta-lactamase producing organisms:
Upper respiratory tract infections (tonsillitis, sinusitis)
Lower respiratory tract infections (bronchitis, pneumonia)
Acute otitis media
Urinary tract infections
Skin & soft tissue infections
Dental infections
Dosage:
Children (≥ 3 months):
Based on amoxicillin component:
20–40 mg/kg/day divided every 8–12 hours
Mild to Moderate infections:
20–25 mg/kg/day
Severe infections:
Up to 40 mg/kg/day
⚠️ Dose must be adjusted based on body weight and severity
Contraindications:
Hypersensitivity to penicillins or beta-lactams
History of co-amoxiclav-related hepatic dysfunction or jaundice
Administration:
Oral use only
Reconstitute with boiled & cooled water up to mark
Shake well before each dose
Administer at the beginning of meals
Complete full treatment course
Drug Interactions:
Allopurinol → ↑ risk of rash
Warfarin / anticoagulants → ↑ bleeding risk
Methotrexate → ↑ toxicity
Probenecid → ↑ amoxicillin levels
Compatibility / Clinical Benefits:
Effective against beta-lactamase producing bacteria
Suitable for pediatric use (low clavulanate dose → better tolerability)
Broad-spectrum antibacterial coverage
Improved compliance due to pleasant flavor
Stability / Storage:
Store dry powder below 25°C
After reconstitution:
Keep refrigerated (2–8°C preferred)
Use within 7 days
Do not freeze
Keep bottle tightly closed
Precautions:
Use cautiously in hepatic impairment
Monitor liver function in prolonged therapy
Risk of antibiotic-associated diarrhea
Use with caution in renal impairment
Avoid unnecessary prolonged use
Side Effects:
Common:
Diarrhea
Nausea
Vomiting
Uncommon:
Rash
Oral thrush
Serious (Rare):
Hepatic dysfunction
Hypersensitivity reactions
Stevens-Johnson Syndrome
Pseudomembranous colitis
Clinical Advantages:
SUBCLAV 156/25 mg is specially designed for:
Young pediatric patients
Better GI tolerability (low clavulanate ratio)
Safe and effective early-line antibiotic therapy
Packaging:
60 mL bottle (after reconstitution)
Measuring cup + oral syringe included